Konis Pharmaceuticals Private Limited
About Konis Pharmaceuticals Private Limited
Data last updated:
Konis Pharmaceuticals Private Limited is a private limited company based in & Distt Solan Hp, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 May 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24230HP2005PTC028351. Its GSTIN is 02AACCK6687Q1ZW (Himachal Pradesh). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Jhansi Rani Seelam (Manager) and Rama Sanjeevareddy Seelam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Village & Post Office Saproonnear Govt. Middle School Saproon, & Distt Solan Hp, Himachal Pradesh, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.91 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹9.92 Lakh (net margin 1%) and EBITDA of ₹40.95 Lakh (EBITDA margin 4.1%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 8% over five years.
The company has about 20 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Konis Pharmaceutical. As per MCA filings, the company has open charges of ₹2.62 Cr on record. Court records list 12 cases involving the company, including 2 filed by the company and 10 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressVillage & Post Office Saproonnear Govt. Middle School Saproon, & Distt Solan Hp, Himachal Pradesh, India
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Konis Pharmaceuticals Private Limited
The main business activity of Konis Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Konis Pharmaceuticals Private Limited FY 2025 filings available
Konis Pharmaceuticals Private Limited reported revenue of ₹9.91 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Konis Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 3% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Konis Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹40.95 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹9.92 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Konis Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Konis Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Konis Pharmaceuticals Private Limited
Konis Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tarun Biotech Private Limited | ₹9.96 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Aurangabad, Maharashtra, India |
| Base Metal Chlorinations Private Limited | ₹9.95 Cr (FY 2025) | •••• | •••• | -60.0% | •••• | Vadodara, Gujarat, India |
| Acekinetics Healthcare Private Limited | ₹9.95 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Chandigarh, India |
| Shantam Pharmaceuticals Pvt Ltd | ₹9.94 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Rajkot, Gujarat, India |
| Gelmek Healthcare Private Limited | ₹9.92 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Moraiya, Ahmedabad, Gujarat, India |
| Konis Pharmaceuticals Private Limited this company | ₹9.91 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | & Distt Solan Hp, Himachal Pradesh, India |
| Ventus Pharmaceuticals Private Limited | ₹9.89 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Panchkula, Haryana, India |
| Erweka (India) Private Limited | ₹9.88 Cr (FY 2025) | •••• | •••• | 43.0% | •••• | Ahmedabad, Gujarat, India |
| Medilloyd Medicament Private Limited | ₹9.88 Cr (FY 2020) | •••• | •••• | 11.0% | •••• | Cuttack, Odisha, India |
| Value Formulations Private Limited | ₹9.88 Cr (FY 2024) | •••• | •••• | 14.0% | •••• | Lucknow, Uttar Pradesh, India |
| Verdin Health Care (OPC) Private Limited | ₹9.85 Cr (FY 2025) | •••• | •••• | 151.0% | •••• | Yavatmal, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Konis Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Konis Pharmaceuticals Private Limited
Konis Pharmaceuticals Private Limited is audited by MUDILI VIJAYA KRISHNA AND CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MUDILI VIJAYA KRISHNA AND CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Konis Pharmaceuticals Private Limited
Konis Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jhansi Rani Seelam | Manager | 31 Jul 2020 | 6 Years 2 Months | Current |
| Rama Sanjeevareddy Seelam Also directs: Konis Hypodermic Devices Private Limited | Director | 07 Mar 2022 | 4 Years 7 Months | Current |
Ownership and Shareholding of Konis Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Konis Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 May 2025 | Hdfc Bank Limited | ₹18.58 Lakh | Open |
| 10 Oct 2024 | Hdfc Bank Limited | ₹95.48 Lakh | Open |
| 04 Sep 2023 | Hdfc Bank Limited | ₹30.4 Lakh | Open |
| 22 Mar 2022 | Hdfc Bank Limited | ₹17.85 Lakh | Open |
| 14 Mar 2006 | Punjab National Bank | ₹1 Cr | Open |
Total charge records: 5 View all charges
Legal Cases of Konis Pharmaceuticals Private Limited
Konis Pharmaceuticals Private Limited has 12 court cases on record: 2 filed by Konis Pharmaceuticals, 10 filed against it. 1 case is pending and 11 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 5 | 1 |
| High courts | 5 | 5 | 0 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Madras High Court | Civil suit | Filed against the company by Shield Health Care Private Limited | Disposed |
| Bombay High Court | Court case (CHOL) | Filed against the company by Lupin Limited | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Lupin Limited | Disposed |
| Bombay High Court | Court case (S) | Filed against the company by Lupin Limited | Disposed |
| District court, Prakasham, Andhra Pradesh | Court case (SC.NDPS) | Filed against the company by State of Andhra Pradesh | Pending |
Full case history
All 12 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Konis Pharmaceuticals Private Limited
Konis Pharmaceuticals operates one associated brand: Konis Pharmaceutical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures high-quality pharmaceutical products, including tablets, capsules, syrups, suspensions, pellets, and injectables. | konispharma.com |
Employees and EPFO Compliance at Konis Pharmaceuticals Private Limited
Konis Pharmaceuticals Private Limited has a workforce of 20 employees as of Mar 30, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Konis Pharmaceuticals Private Limited
Konis Pharmaceuticals Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Jaya Rami Raddy Seelam ceased to be Director on 07 Mar 2022.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Konis Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Konis Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Konis Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Konis Pharmaceuticals Private Limited
Konis Pharmaceuticals has 4 GST registrations: 3 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AACCK6687Q1ZW | Himachal Pradesh | Active | 01 Jul 2017 |
| 02AACCK6687Q3ZU | Himachal Pradesh | Active | 28 Feb 2025 |
| 36AACCK6687Q1ZL | Telangana | Active | 24 Jul 2023 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Konis Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Konis Pharmaceuticals Private Limited
Konis Pharmaceuticals is an active private limited company based in & Distt Solan Hp, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 May 2005 (21+ years old) and is registered under CIN U24230HP2005PTC028351.
Konis Pharmaceuticals reported revenue of ₹9.91 Cr for FY 2025 (up 3% YoY).
Konis Pharmaceuticals has 2 current directors:
- Rama Sanjeevareddy Seelam - Director
- Jhansi Rani Seelam - Manager
Konis Pharmaceuticals reported a net profit of ₹9.92 Lakh (net margin 1%) and EBITDA of ₹40.95 Lakh (EBITDA margin 4.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Konis Pharmaceuticals is 10% over three years and 8% over five years. In the latest year (FY 2025) revenue rose 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Konis Pharmaceuticals is 02AACCK6687Q1ZW, registered in Himachal Pradesh. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 02AACCK6687Q3ZU (Himachal Pradesh), 36AACCK6687Q1ZL (Telangana).
The CIN (Corporate Identification Number) of Konis Pharmaceuticals is U24230HP2005PTC028351. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Konis Pharmaceuticals has 12 court cases on record: 2 filed by the company and 10 filed against it. 1 is pending. Most are in the district courts.
Konis Pharmaceuticals was incorporated on 04 May 2005, making it 21+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
The peers of Konis Pharmaceuticals by revenue are Tarun Biotech Private Limited, Base Metal Chlorinations Private Limited, Acekinetics Healthcare Private Limited, Shantam Pharmaceuticals Pvt Ltd, Gelmek Healthcare Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Jaya Rami Raddy Seelam ceased to be Director on 07 Mar 2022. Rama Sanjeevareddy Seelam was appointed as Director on 07 Mar 2022. Jhansi Rani Seelam was appointed as Manager on 31 Jul 2020. Konis Pharmaceuticals has 4 board changes on record in total.